Thomas Hoock

777 total citations
9 papers, 551 citations indexed

About

Thomas Hoock is a scholar working on Oncology, Rheumatology and Immunology. According to data from OpenAlex, Thomas Hoock has authored 9 papers receiving a total of 551 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Oncology, 3 papers in Rheumatology and 3 papers in Immunology. Recurrent topics in Thomas Hoock's work include Rheumatoid Arthritis Research and Therapies (3 papers), Cytokine Signaling Pathways and Interactions (3 papers) and Cellular Mechanics and Interactions (2 papers). Thomas Hoock is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (3 papers), Cytokine Signaling Pathways and Interactions (3 papers) and Cellular Mechanics and Interactions (2 papers). Thomas Hoock collaborates with scholars based in United States and Serbia. Thomas Hoock's co-authors include Ira M. Herman, David DeNofrio, Luanne L. Peters, Samuel E. Lux, Roy Fleischmann, Alan Kivitz, Nils Kinnman, Nemanja Damjanov, Francesco G. Salituro and Luc J. Farmer and has published in prestigious journals such as The Journal of Cell Biology, Neurology and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Thomas Hoock

8 papers receiving 541 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Hoock United States 6 264 189 107 96 65 9 551
Marleen M.R. Petit Belgium 15 513 1.9× 229 1.2× 82 0.8× 73 0.8× 55 0.8× 17 878
Toshifumi Azuma Japan 8 335 1.3× 315 1.7× 56 0.5× 23 0.2× 56 0.9× 13 654
Eleonora Presman United States 9 470 1.8× 99 0.5× 67 0.6× 22 0.2× 30 0.5× 10 640
Arkadiusz Welman United Kingdom 15 312 1.2× 91 0.5× 126 1.2× 91 0.9× 18 0.3× 17 571
Sumeda Nandadasa United States 13 354 1.3× 260 1.4× 73 0.7× 28 0.3× 19 0.3× 18 645
Heesuk Zang United States 8 649 2.5× 121 0.6× 159 1.5× 16 0.2× 65 1.0× 8 934
Adi D. Dubash United States 17 759 2.9× 466 2.5× 134 1.3× 25 0.3× 65 1.0× 22 1.2k
Susana Miravet Spain 8 911 3.5× 334 1.8× 114 1.1× 24 0.3× 34 0.5× 10 1.1k
Keiko Mayne Australia 12 590 2.2× 397 2.1× 96 0.9× 23 0.2× 32 0.5× 17 849
José Piedra Spain 7 867 3.3× 318 1.7× 107 1.0× 23 0.2× 34 0.5× 9 1.0k

Countries citing papers authored by Thomas Hoock

Since Specialization
Citations

This map shows the geographic impact of Thomas Hoock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Hoock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Hoock more than expected).

Fields of papers citing papers by Thomas Hoock

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Hoock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Hoock. The network helps show where Thomas Hoock may publish in the future.

Co-authorship network of co-authors of Thomas Hoock

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Hoock. A scholar is included among the top collaborators of Thomas Hoock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Hoock. Thomas Hoock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Mahajan, Sudipta, James K. Hogan, Luke S. Oh, et al.. (2015). VX-509 (Decernotinib) Is a Potent and Selective Janus Kinase 3 Inhibitor That Attenuates Inflammation in Animal Models of Autoimmune Disease. Journal of Pharmacology and Experimental Therapeutics. 353(2). 405–414. 49 indexed citations
2.
3.
4.
5.
Catlett, Ian M., Xia Luo, Marina S. Penney, et al.. (2012). THU0141 Biomarker assessment of VX-509, an investigational selective JAK3 inhibitor, in healthy volunteers. Annals of the Rheumatic Diseases. 71. 203–203. 1 indexed citations
6.
Farmer, Luc J., Guy W. Bemis, John E. Cochran, et al.. (2008). Discovery and SAR of novel 4-thiazolyl-2-phenylaminopyrimidines as potent inhibitors of spleen tyrosine kinase (SYK). Bioorganic & Medicinal Chemistry Letters. 18(23). 6231–6235. 25 indexed citations
7.
Hoock, Thomas, Luanne L. Peters, & Samuel E. Lux. (1997). Isoforms of Ankyrin-3 That Lack the NH2-terminal Repeats Associate with Mouse Macrophage Lysosomes. The Journal of Cell Biology. 136(5). 1059–1070. 61 indexed citations
8.
Hoock, Thomas, et al.. (1991). Beta actin and its mRNA are localized at the plasma membrane and the regions of moving cytoplasm during the cellular response to injury.. The Journal of Cell Biology. 112(4). 653–664. 201 indexed citations
9.
DeNofrio, David, Thomas Hoock, & Ira M. Herman. (1989). Functional sorting of actin isoforms in microvascular pericytes.. The Journal of Cell Biology. 109(1). 191–202. 120 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marleen M.R. Petit Breakdown of academic impact, for papers by Toshifumi Azuma Breakdown of academic impact, for papers by Eleonora Presman Breakdown of academic impact, for papers by Arkadiusz Welman Breakdown of academic impact, for papers by Sumeda Nandadasa Breakdown of academic impact, for papers by Heesuk Zang Breakdown of academic impact, for papers by Adi D. Dubash Breakdown of academic impact, for papers by Susana Miravet Breakdown of academic impact, for papers by Keiko Mayne Breakdown of academic impact, for papers by José Piedra
Rankless by CCL
2026